Lung Cancer Clinical Trials in Detroit

Showing 341-342 of 342 trials

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

NCT00082472

This study is intended to show whether inhaled chemotherapy can be added to a standard IV chemotherapy regime, to investigate the additional toxicities and to show initial evidence of efficacy of the combination.

NSCLC

Zivena30 participantsStarted Jan 2004

New Haven, Connecticut, United States • Las Vegas, Nevada, United States • Las Vegas, Nevada, United States +3 more locations

UNKNOWNPHASE1955 miles

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

NCT00062907

The purpose of this trial is to examine the safety and immunogenicity of a therapeutic vaccine regimen with recombinant DNA and adenovirus expressing L523S protein in patients with early stage non-small cell lung cancer. The vaccine regimen will consist of two fixed doses of recombinant DNA (pVAX/L523S) followed by two doses of recombinant adenovirus (Ad/L523S). The trial will evaluate the dose escalation of Ad/L523S through three cohorts of patients.

Non-Small Cell Lung Cancer

Corixa Corporation9 participantsStarted May 2003

Ocoee, Florida, United States • Dallas, Texas, United States • Tyler, Texas, United States +2 more locations

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Lung Cancer Trials in Other Cities

Other Conditions in Detroit